Ascelia Pharma AB (publ) (STO:ACE)
Sweden · Delayed Price · Currency is SEK 0.5040
-0.0050 (-0.98%)
Jul 24, 2026, 5:29 PM CET
Ascelia Pharma AB Market Cap
Ascelia Pharma AB has a market cap or net worth of 67.3 million as of July 24, 2026. Its market cap has decreased by -87.79% in one year.
Market Cap
67.30M
Enterprise Value
34.10M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.50
ChartMarket Cap Chart
Since March 13, 2019, Ascelia Pharma AB's market cap has decreased from 562.35M to 67.30M, a decrease of -88.03%. That is a compound annual growth rate of -25.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 67.30M | -83.50% |
| Dec 30, 2025 | 407.88M | 45.35% |
| Dec 30, 2024 | 280.63M | 146.68% |
| Dec 29, 2023 | 113.76M | -77.38% |
| Dec 30, 2022 | 503.00M | -49.95% |
| Dec 30, 2021 | 1.00B | -36.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alligator Bioscience AB | 123.49M |
| OncoZenge AB | 105.22M |
| Alzinova AB | 102.27M |
| Annexin Pharmaceuticals AB | 88.24M |
| AcouSort AB | 77.46M |
| Spago Nanomedical AB | 75.42M |
| Pila Pharma AB | 58.02M |
| 2cureX AB | 57.43M |